You are here

anal cancer

FDA unsurprisingly brings down the hammer on Incyte's PD-1 — drawing a line for future accelerated approvals

Endpoints

Mon, 07/26/21 - 09:36 am

Incyte’s PD-(L)1 inhibitor headed for an ODAC showdown next month

Endpoints

Thu, 05/13/21 - 12:06 pm

Incyte makes bid to join the checkpoint inhibitor club

Pharmaforum

Tue, 02/2/21 - 10:25 am

Incyte lands priority review for PD-1 inhibitor in anal cancer

Fierce Biotech

Fri, 01/22/21 - 10:31 am

priority review

'More bang for buck' from GSK's Cervarix

Fierce Pharma

Tue, 08/23/11 - 12:04 pm

Merck's Gardasil wins approval for anal cancer

Reuters

Thu, 12/23/10 - 08:27 am

Merck’s Gardasil Should Be Approved in Anal Cancer, FDA Says

Bloomberg

Tue, 11/2/10 - 11:12 am